A minimally invasive cryoablation system indicated for the local treatment of breast cancer in patients ≥ 70 years of age with biologically low-risk tumors ≤ 1.5 centimeters (cm) in size and treated with adjuvant endocrine therapy, including patients not suitable for surgery for breast cancer treatment.